Please login to the form below
Appointments
-
Ablynx reshuffles its board againDr Bo Jesper Hansen resigns from the Belgium biotech's board
-
Bedrock Communications strengthens operationsAgency appoints six new team members
-
Ashfield appoints former Havas Health CEO Doug Burcin becomes president at the agency
-
Avril Lee joins Burson-Marsteller in global roleBased in the UK, she joins the firm as its deputy global healthcare practice chair
-
Rubius Therapeutics adds to its board of directorsFrancis Cuss and Catherine Sohn join the US biotech
-
BioStrata expands leadership teamHelen Stewart-Miller and Craig Townsend are promoted into new roles
-
Professor Thomas Cech joins Storm TherapeuticsHe takes up a scientific advisor role at the group
-
W2O bolsters its commercialisation offering Rita Glaze joins the firm as leader of value, pricing and market access practice
-
Narrative Health appoints a new directorGillian Newbold joins the team from Healthcare Research Worldwide
-
Christian Pangratz to head up Sterna BiologicalsHe joins as CEO having previously served as senior VP for Vectura Group
-
Juno Therapeutics names Cindy Elkins as CIOShe joins the biopharma from Genentech, where she was VP of IT
-
Astellas strengthens US and Canadian leadership teamSteve Sabus, Lynn Gerber and Kevin O’Keefe are promoted to new roles
-
Celgene’s CEO Mark Alles is appointed as chairman
He succeeds Bob Hugin who is retiring from the pharma firm
-
Alexion appoints new senior VP for EMEAC regionCamilla Harder Hartvig will lead commercial activities from Zurich, Switzerland
-
Pfizer’s Alan Maine moves to EdelmanHe joins the communications firm as its senior director
-
Dr Sotirios Stergiopoulos leaves Shire for IpsenHe becomes the French biopharma’s chief medical officer
-
Merck appoints new chief information officerDirk Toepfer joins the group from Metro Systems, where he was head of IT
-
Linda Law joins Advicenne as US VP, clinical development and med affairsShe will oversee the biopharma’s developments with its dTRA candidate
-
Amryt Pharma appoints new regulatory affairs head
Derval O’Carroll joins the rare disease-focused biopharma from Retrophin
-
Robert Freisen joins Ablynx
He will take the role of chief scientific officer, effective March 1
Featured jobs
- EU Head of Business Development and Client Service
-
Exceptional packge and bonus
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Digital Account Director
-
Salary TBC
-
Creative/ Medical Writer
-
Circa £35, 000 With Benefits
-
Senior Medical Writer
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Scientific Director – Medical Communications
-
Salary TBC
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Associate Director – Social Healthcare – London
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Freelance AM/ AD Healthcare Advertising
-
£350-400 depending on experience
- Freelance Senior Account Manager / Account Director - Healthcare...
-
£350-400 depending on experience
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Senior Account Manager, Medical Communications, London
-
Excellent package
Subscribe to our email news alerts
- Novo uses voucher for speedy answer on oral semaglutide
- Is Orkambi deal close? Vertex meets again today with NHS England
- Amgen, Servier heart failure drug clears trial hurdle
- NHS needs £900m a year to avoid crippling staff shortages
- Leading Edge, a Lucid Group company, strengthens its senior clients services team
- Quick Change
PMHub
Videum Health
Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...
Latest intelligence
- Brain power: fresh approaches to Alzheimer’s drug discovery
- New alliances are learning from past mistakes and breaking down research barriers...
- Genomics integration: can the NHS rise to the challenge?
- Experts gather to discuss the UK’s genomic landscape...
- “Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
- The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
Quick links
Infographics
